Neoadjuvant Chemotherapy Response Assessment by Combined PET-MRI in Borderline and Locally Advanced Pancreatic Adenocarcinoma.

NCT03202199 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

125

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Adenocarcinoma

Interventions

DEVICE: PET/MRI

Sponsor

Assistance Publique - Hôpitaux de Paris